YOKNEAM, ISRAEL--(Marketwire -03\/29\/12)- Syneron Medical Ltd. (NASDAQ: ELOS - News), the leading global aesthetic device company, announced today that it will host a joint symposium on Body Shaping featuring its VelaShape body contouring system and the recently acquired UltraShape focused ultrasound fat lipolysis system at the 2012 Anti-Aging Medicine World Congress & Medispa Conference in Monte Carlo. The symposium will feature an overview of Syneron's complementary product offerings for body shaping and a review of the pre-clinical and clinical experience with the UltraShape system. It will also feature two thought-leading physician speakers that will discuss their experience with the VelaShape and UltraShape systems. <\/p>\n
Event: Brunch Symposium - \"NEW Opportunities & Trends in the Dynamic Body Shaping Arena\" <\/p>\n
Speakers: Shimon Eckhouse, Ph.D., Co-founder and Chairman of the Board of Directors of Syneron Medical <\/p>\n
Lior Greenbaum, Ph.D., Clinical Director of UltraShape <\/p>\n
Chris Inglefield, M.D., Plastic Surgery Clinic at the London Bridge Hospital <\/p>\n
Dean Adel, M.D., Head of Plastic Surgery Division at Rabin - Schneider Medical Center, Petah Tikva <\/p>\n
Click here for speaker biographies and event agenda. <\/p>\n
Time: 11:00 am <\/p>\n
Location: Le Meridien Beach Plaza Hotel 22 Avenue Princesse Grace Monte Carlo 98000 Monaco <\/p>\n
Louis P. Scafuri, Chief Executive Officer of Syneron Medical, said, \"The symposium provides the first opportunity following the acquisition of UltraShape for Syneron to highlight the synergies associated with our proprietary technologies and the UltraShape focused ultrasound technology to deliver comprehensive body shaping treatments. More than 7,000 VelaShape systems have been sold worldwide since its launch, demonstrating the strong patient demand for body contouring treatments with our safe and efficacious els technology. We believe there is a tremendous opportunity to offer our VelaShape customers the UltraShape system to further enhance their patients' body shaping results. Syneron remains committed to be the global market leader in non-invasive body contouring.\" <\/p>\n<\/p>\n
Continued here: YOKNEAM, ISRAEL--(Marketwire -03\/29\/12)- Syneron Medical Ltd. (NASDAQ: ELOS - News), the leading global aesthetic device company, announced today that it will host a joint symposium on Body Shaping featuring its VelaShape body contouring system and the recently acquired UltraShape focused ultrasound fat lipolysis system at the 2012 Anti-Aging Medicine World Congress & Medispa Conference in Monte Carlo. The symposium will feature an overview of Syneron's complementary product offerings for body shaping and a review of the pre-clinical and clinical experience with the UltraShape system. Continue reading
\nSyneron to Highlight New Opportunities & Trends in the Dynamic Body Shaping Market at the 2012 Anti-Aging Medicine ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"